How Hologic Stabilized Its Breast Health Business & Is Positioned for Explosive Growth!

Hologic Inc. reported its financial performance for the second quarter of fiscal 2025, showcasing a nuanced blend of strategic achievements and challenges impacting future growth. The company reported total revenue of $1.005 billion, a slight decrease of 0.5% in constant currency terms, yet aligning with the higher end of guidance expectations. Non-GAAP earnings per share remained consistent with the previous year at $1.03, buoyed by improvements in gross margin and aided by share buybacks and a lower tax rate.